Xcout Intel
Fluicell
Fluicell develops precision-engineered biological tissues and single-cell bioprinting technologies for regenerative medicine and drug screening. Using its proprietary platforms, including Nexocyte and Biopixlar, the company creates transplantable tissues to target diseases such as type 1 diabetes and provides advanced tools and screening models for pharmaceutical and academic partners.
Subscribe to see Fluicell’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Fluicell at a glance
Fluicell is a health care company headquartered in Sweden. Xcout tracks 12 named people at Fluicell, including Carolina Trkulja (CHIEF EXECUTIVE OFFICER).
Fluicell leadership
- Carolina TrkuljaCHIEF EXECUTIVE OFFICER
- Joakim WahlbergChief Financial Officer
- Jonas HannestadCHIEF MARKETING & COMMUNICATIONS OFFICER
- Gavin D. M. JeffriesCHIEF TECHNOLOGY OFFICER and co-founder
- Niklas FriskChairman of the board
- Alex ScheepersBoard member
6 more named people on record for Fluicell, with roles, board committees and tenure — see the full roster →
Fluicell competitors
A few of Fluicell's closest competitors — see the full list of competitors and alternatives →
Obatala Sciences, Inc. is a biotechnology company that provides organ-on-a-chip solutions for research, with its office located in New Orleans, Louisiana.
Bit Bio is a UK biotechnology company that develops technologies for precisely programming human cells, including its opti-ox platform for producing consistent, scalable cell types. It serves biomedical researchers, drug developers, and regenerative-medicine and cell-therapy developers with engineered human cells and related tools.
AcroCyte Therapeutics, Inc. is a biotechnology company dedicated to overcoming common laboratory challenges through its proprietary R³CE rapid, reproducible, rare cell 3D expansion technology. Recognized with awards such as the Taiwan National Innovation Award, the company focuses on advancing biomedical research and cell-based applications.
iOrganBio is a biotechnology company founded in 2024 that develops AI-powered platforms for the precision engineering and manufacturing of human cells and organoids. The company's CellForge platform aims to create reproducible human cell models for research applications, including cardiac disease studies and biological simulation.
Established in 2010 and headquartered in Tokyo, Japan, Cyfuse Biomedical K.K. focuses on the creation, production, and distribution of regenerative medicine solutions. The company is actively involved in developing cell-based products for therapeutic regeneration, and it also undertakes contract work for cellular product research and development. Furthermore, Cyfuse Biomedical offers advanced Bio 3D Printers, which are instrumental in regenerating a variety of tissues and organs, including cartilage, bones, blood vessels, and nerves. Their specialized equipment includes 'regenova,' a bio 3D printer enabling three-dimensional cell stacking, and 'S-PIKE,' designed for forming complex 3D structures from cells.
Biodimension Technology Private Limited is a biotechnology company headquartered in Bangalore, Karnataka, India. The firm specializes in developing and manufacturing biofabricated human tissue models for research and testing applications.
Get Fluicell's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Fluicell in Xcout Intel
- 12 named people with titles, LinkedIn and board committees
- The full competitor set, tracking, exports and API access